Skip to main content

Advertisement

Table 1 Baseline characteristics of the study population

From: Predictive value of non-fasting remnant cholesterol for short-term outcome of diabetics with new-onset stable coronary artery disease

Variables Outcome P-value
Present (n = 47) Absent (n = 281)
Risk factors
 Age (years) 59.2 ± 9.4 59.4 ± 9.3 0.891
 Male gender 30 (63.8) 210 (74.7) 0.154
 BMI (kg/m2) 25.9 ± 3.2 25.4 ± 3.0 0.067
 Current smoking 21 (44.7) 160 (56.9) 0.153
 Hypertension 36 (76.6) 226 (80.4) 0.557
 Hyperlipidemia 95 (80.5) 77 (77.8) 0.557
 PVD 0 (0.0) 6 (2.1) 0.599
 Prior Stroke 1 (2.1) 12 (4.3) 0.702
 Family history of CAD 3 (6.4) 32 (11.4) 0.444
 LV-EF (%) 61.7 ± 9.5 62.1 ± 8.1 0.805
Laboratory test
 hs-CRP (mg/L) 6.8 ± 1.7 6.0 ± 1.4 0.805
 Neutrophil Count (109/L) 3.9 ± 1.0 3.8 ± 1.2 0.797
 Fibrinogen (g/L) 138.9 ± 16.6 137.2 ± 14.6 0.095
 Hemoglobin A1C (g/L) 7.3 ± 1.5 6.8 ± 1.4 0.016
 Creatinine (umol/L) 77.3 ± 15.9 76.2 ± 15.5 0.654
 NT-pro-BNP (fmol/mL) 777.9 ± 736.0 731.8 ± 560.1 0.619
Lipid profile
 Remnant Cholestero (mmol/L) 0.6 ± 0.6 0.6 ± 0.4 0.390
 Triglycerides (mmol/L) 1.9 ± 0.8 1.7 ± 0.9 0.072
 Total Cholesterol (mmol/L) 4.2 ± 1.3 3.9 ± 0.9 0.170
 LDL-C (mmol/L) 2.5 ± 1.0 2.3 ± 0.8 0.208
 HDL-C (mmol/L) 1.1 ± 0.3 1.1 ± 0.3 0.981
 Lipoprotein (a) (mg/L) 272.3 ± 286.1 240.1 ± 237.4 0.405
 Apoprotein A-1 (g/L) 1.5 ± 0.3 1.4 ± 0.3 0.386
 Apoprotein B (g/L) 1.1 ± 0.3 1.0 ± 0.3 0.048
 Gensini scores (points) 45.1 ± 41.8 32.0 ± 35.2 0.022
 DES Implantation 31 (73.8) 158 (68.7) 0.825
Medicine treatment
 Aspirin 46 (97.9) 274 (97.5) 1.000
 Clopidogrel 45 (95.7) 269 (95.7) 1.000
 Statin 47 (100.0) 272 (96.8) 0.368
 Beta-blocker 42 (89.4) 229 (81.5) 0.218
 ACE-I/ARB 30 (63.8) 213 (75.8) 0.105
  1. BMI body mass index, PVD peripheral vascular disease, CAD coronary artery disease, hs-CRP high sensitivity C-reactive protein, NT-pro-BNP N-terminal pro-Brain natriuretic peptide, LV-FE left ventricular ejection fraction, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, DES drug eluting stent, ACE-I angiotensin converting enzyme inhibitors, ARB angiotensin receptor blocker